Showing 1 - 20 results of 26,226 for search '"Immunotherapy, Adoptive"', query time: 1.03s Refine Results
1
Academic Journal

Authors: Soltantoye T; Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. tahereh.soltantoye@gmail.com., Akbari B; Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. behniaceae@gmail.com., Mirzaei HR; Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. h-mirzaei@tums.ac.ir., Hadjati J; Department of Medical Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. hajatij@gmail.com.

Source: Iranian journal of allergy, asthma, and immunology [Iran J Allergy Asthma Immunol] 2022 Dec 24; Vol. 21 (6), pp. 630-637. Date of Electronic Publication: 2022 Dec 24.

Publication Type: Journal Article

Journal Info: Publisher: Tehran University of Medical Sciences Country of Publication: Iran NLM ID: 101146178 Publication Model: Electronic Cited Medium: Internet ISSN: 1735-5249 (Electronic) Linking ISSN: 17351502 NLM ISO Abbreviation: Iran J Allergy Asthma Immunol Subsets: MEDLINE

PDF Full Text
2
Academic Journal

Authors: Larkin H

Source: JAMA [JAMA] 2022 Dec 13; Vol. 328 (22), pp. 2201.

Publication Type: Journal Article

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

HTML Full Text     PDF Full Text
3
Academic Journal

Authors: Choi G; College of Pharmacy, Ewha Womans University, Seoul 03760, Korea., Shin G; College of Pharmacy, Ewha Womans University, Seoul 03760, Korea., Bae S; College of Pharmacy, Ewha Womans University, Seoul 03760, Korea.

Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Sep 28; Vol. 19 (19). Date of Electronic Publication: 2022 Sep 28.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601 (Electronic) Linking ISSN: 16604601 NLM ISO Abbreviation: Int J Environ Res Public Health Subsets: MEDLINE

HTML Full Text     PDF Full Text
4
Academic Journal

Authors: Asmamaw Dejenie T; Department of Biochemistry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia., Tiruneh G/Medhin M; Department of Biochemistry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia., Dessie Terefe G; Department of Biochemistry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia., Tadele Admasu F; Department of Biochemistry, College of Medicine and Health Science Arbaminch University, Arbaminch, Ethiopia., Wale Tesega W; Department of Biochemistry, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia., Chekol Abebe E; Department of Biochemistry, College of Medicine and Health Science Arbaminch University, Arbaminch, Ethiopia.

Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (6), pp. 2114254. Date of Electronic Publication: 2022 Sep 12.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

HTML Full Text     PDF Full Text
5
Academic Journal

Authors: Isser A; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Johns Hopkins Translational ImmunoEngineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA., Silver AB; Johns Hopkins Translational ImmunoEngineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, 21287, USA.; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA., Pruitt HC; Department of Chemical and Biomolecular Engineering, Johns Hopkins University Whiting School of Engineering, Baltimore, MD, 21287, USA.; Institute for NanoBioTechnology, Johns Hopkins University Whiting School of Engineering, Baltimore, MD, 21287, USA., Mass M; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA., Elias EH; Department of Biology, Johns Hopkins University Krieger School of Arts and Sciences, Baltimore, MD, 21287, USA., Aihara G; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA., Kang SS; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA., Bachmann N; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA., Chen YY; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA., Leonard EK; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Johns Hopkins Translational ImmunoEngineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA., Bieler JG; Johns Hopkins Translational ImmunoEngineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA., Chaisawangwong W; Johns Hopkins Translational ImmunoEngineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA., Choy J; Johns Hopkins Translational ImmunoEngineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Institute for NanoBioTechnology, Johns Hopkins University Whiting School of Engineering, Baltimore, MD, 21287, USA.; Department of Materials Science and Engineering, Johns Hopkins University Whiting School of Engineering, Baltimore, MD, 21287, USA., Shannon SR; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Johns Hopkins Translational ImmunoEngineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA., Gerecht S; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Department of Chemical and Biomolecular Engineering, Johns Hopkins University Whiting School of Engineering, Baltimore, MD, 21287, USA.; Institute for NanoBioTechnology, Johns Hopkins University Whiting School of Engineering, Baltimore, MD, 21287, USA.; Department of Materials Science and Engineering, Johns Hopkins University Whiting School of Engineering, Baltimore, MD, 21287, USA.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA., Weber JS; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY, 10016, USA., Spangler JB; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Department of Chemical and Biomolecular Engineering, Johns Hopkins University Whiting School of Engineering, Baltimore, MD, 21287, USA.; Department of Materials Science and Engineering, Johns Hopkins University Whiting School of Engineering, Baltimore, MD, 21287, USA.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Department of Ophthalmology, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA., Schneck JP; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA. jschnec1@jhmi.edu.; Johns Hopkins Translational ImmunoEngineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA. jschnec1@jhmi.edu.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA. jschnec1@jhmi.edu.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA. jschnec1@jhmi.edu.; Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA. jschnec1@jhmi.edu.

Source: Nature communications [Nat Commun] 2022 Oct 14; Vol. 13 (1), pp. 6086. Date of Electronic Publication: 2022 Oct 14.

Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

HTML Full Text     PDF Full Text
6
Academic Journal

Authors: Bouchkouj N; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Lin X; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Wang X; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Przepiorka D; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Xu Z; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Purohit-Sheth T; Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA., Theoret M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Source: The oncologist [Oncologist] 2022 Oct 01; Vol. 27 (10), pp. 892-899.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

HTML Full Text     PDF Full Text
7
Academic Journal

Authors: Larkin HD

Source: JAMA [JAMA] 2022 Jun 14; Vol. 327 (22), pp. 2182.

Publication Type: Journal Article

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE

HTML Full Text     PDF Full Text
8
Academic Journal

Authors: Heard A; Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Landmann JH; Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Hansen AR; Department of Pediatrics, Washington University School of Medicine, Saint Louis, MO, USA., Papadopolou A; Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany., Hsu YS; Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Selli ME; Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Warrington JM; Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Lattin J; Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Chang J; Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Ha H; Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA., Haug-Kroeper M; Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany., Doray B; Division of Hematology, Washington University School of Medicine, Saint Louis, MO, USA., Gill S; Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Ruella M; Division of Hematology and Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Hayer KE; Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Weitzman MD; Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Green AM; Department of Pediatrics, Washington University School of Medicine, Saint Louis, MO, USA.; Center for Genome Integrity, Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO, USA., Fluhrer R; Biochemistry and Molecular Biology, Institute of Theoretical Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany., Singh N; Division of Oncology, Washington University School of Medicine, Saint Louis, MO, USA. nathan.singh@wustl.edu.

Source: Nature communications [Nat Commun] 2022 Jun 11; Vol. 13 (1), pp. 3367. Date of Electronic Publication: 2022 Jun 11.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

HTML Full Text     PDF Full Text
9
Periodical

Authors: Ledford H

Source: Nature [Nature] 2023 Jan; Vol. 613 (7945), pp. 626-628.

Publication Type: News

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

10
Academic Journal

Authors: An L; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Lin Y; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Deng B; Cytology Laboratory, Beijing Boren Hospital, Beijing, China., Yin Z; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Zhao D; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Ling Z; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Wu T; Department of Hematopoietic Cell Transplantation, Beijing Boren Hospital, Beijing, China., Zhao Y; Department of Hematopoietic Cell Transplantation, Beijing Boren Hospital, Beijing, China., Chang AH; Clinical Translational Research Center, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China., Tong C; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China., Liu S; Department of Hematology, Beijing Boren Hospital, No.6 South Zhengwangfen, Fengtai District, Beijing, 100070, China. liusy@borenhospital.com.

Source: BMC cancer [BMC Cancer] 2022 Apr 12; Vol. 22 (1), pp. 393. Date of Electronic Publication: 2022 Apr 12.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

HTML Full Text     PDF Full Text
11
Academic Journal

Authors: Zhang X; Hebei Yanda Lu Daopei Hospital, Langfang, China.; Beijing Lu Daopei Institute of Hematology, No. 22 Tongji South Rd, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing, 100176, China., Yang J; Hebei Yanda Lu Daopei Hospital, Langfang, China.; Beijing Lu Daopei Institute of Hematology, No. 22 Tongji South Rd, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing, 100176, China., Li J; Hebei Yanda Lu Daopei Hospital, Langfang, China.; Beijing Lu Daopei Institute of Hematology, No. 22 Tongji South Rd, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing, 100176, China., Li W; Hebei Yanda Lu Daopei Hospital, Langfang, China., Song D; Hebei Yanda Lu Daopei Hospital, Langfang, China., Lu XA; Immunochina Pharmaceuticals Co., Ltd., Beijing, China., Wu F; Immunochina Pharmaceuticals Co., Ltd., Beijing, China., Li J; Hebei Senlang Biotechnology, Shijiazhuang, China., Chen D; Hebei Senlang Biotechnology, Shijiazhuang, China., Li X; Beijing Doing Biomedical Co., Ltd., Beijing, China., Xu Z; Bioceltech Therapeutics Co., Ltd., Beijing, China., Liu S; Tianjin Mycure Medical Technology Co., Ltd., Tianjin, China., Li Z; Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing, China., Ying K; Department of Engineering Physics, Medical Physics and Engineering Institute, Tsinghua University, Beijing, China., Lu P; Hebei Yanda Lu Daopei Hospital, Langfang, China. peihua_lu@126.com.; Beijing Lu Daopei Institute of Hematology, No. 22 Tongji South Rd, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing, 100176, China. peihua_lu@126.com.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Mar; Vol. 71 (3), pp. 689-703. Date of Electronic Publication: 2021 Aug 07.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

HTML Full Text     PDF Full Text
12
Academic Journal

Authors: Vu K; Department of Oncology/Hematology, Kaiser Permanente Santa Clara Medical Center, Santa Clara, CA., Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Palo Alto, CA.

Source: Blood advances [Blood Adv] 2023 Feb 14; Vol. 7 (3), pp. 375-378.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

13
Academic Journal

Authors: Chen J; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China., Hu J; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China., Gu L; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China., Ji F; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China., Zhang F; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China., Zhang M; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China., Li J; Nanjing Blue Shield Biotechnology Co., Ltd., Nanjing, 210023, China., Chen Z; Nanjing Blue Shield Biotechnology Co., Ltd., Nanjing, 210023, China., Jiang L; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China., Zhang Y; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China., Shi R; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China., Ma L; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China., Jia S; Department of Biotherapy, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China., Zhang Y; Department of Pathology, Jinling Hospital of Nanjing University School of Medicine, Nanjing, 210002, China., Zhang Q; Center of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, 210009, China., Liang J; Inner Mongolia Autonomous Region Cancer Hospital, Hohhot, 010010, China., Yao S; Baylor University, 1311 S 5th St, Waco, USA., Hu Z; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China. huzg_2000@126.com., Guo Z; Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, 210023, China. guo@njnu.edu.cn.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Feb; Vol. 72 (2), pp. 409-425. Date of Electronic Publication: 2022 Aug 04.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

14
Academic Journal

Authors: Kiefer T; Klinik am See, Rehabilitationszentrum, Rüdersdorf, Germany; Medical University Brandenburg 'Theodor Fontane', Germany. Electronic address: Thomas.Kiefer-Trendelenburg@klinikamsee.com., Lüders C; Klinik am See, Rehabilitationszentrum, Rüdersdorf, Germany., Völler H; Klinik am See, Rehabilitationszentrum, Rüdersdorf, Germany; Universität Potsdam, Professur für Rehabilitationswissenschaften, humanwissenschaftliche Fakultät, Germany., Daeschlein G; Clinic of Dermatology, Immunology and Allergology, Medical Center Dessau, Medical University Brandenburg 'Theodor Fontane' Medical Center Dessau, Germany.

Source: Transplant immunology [Transpl Immunol] 2023 Feb; Vol. 76, pp. 101770. Date of Electronic Publication: 2022 Dec 05.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9309923 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5492 (Electronic) Linking ISSN: 09663274 NLM ISO Abbreviation: Transpl Immunol Subsets: MEDLINE

15
Academic Journal

Authors: Yang J; Department of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, 610041, China., Zhou W; Department of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, 610041, China., Li D; Department of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, 610041, China., Niu T; Department of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, 610041, China. Electronic address: niuting@wchscu.cn., Wang W; Department of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and National Collaborative Innovation Center, Chengdu, 610041, China. Electronic address: weiwang@scu.edu.cn.

Source: Cancer letters [Cancer Lett] 2023 Jan 28; Vol. 553, pp. 215949. Date of Electronic Publication: 2022 Oct 08.

Publication Type: Review; Journal Article

Journal Info: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE

16
Academic Journal

Authors: Gupta S; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Simic M; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Sagan SA; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Shepherd C; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Duecker J; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Sobel RA; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Dandekar R; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Wu GF; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Wu W; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Pak JE; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Hauser SL; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Lim W; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Wilson MR; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA., Zamvil SS; From the Department of Neurology (S.G., S.A.S., C.S., R.D., S.L.H., M.R.W., S.S.Z.), Weill Institute for Neurosciences, University of California San Francisco, CA; Department of Cellular Molecular Pharmacology (M.S., J.D., W.L.), University of California San Francisco Cell Design Institute, CA; Veterans Affairs Health Care System (R.A.S.), Department of Pathology, Stanford University School of Medicine, CA; Departments of Neurology and Pathology and Immunology (G.F.W.), Washington University in St. Louis, MO; and Chan Zuckerberg Biohub (W.W., J.E.P.), San Francisco, CA. zamvil@ucsf.neuroimmunol.org.

Source: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2023 Jan 19; Vol. 10 (2). Date of Electronic Publication: 2023 Jan 19 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101636388 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 2332-7812 (Electronic) Linking ISSN: 23327812 NLM ISO Abbreviation: Neurol Neuroimmunol Neuroinflamm Subsets: MEDLINE

17
Academic Journal

Authors: Forero-Forero JV; Department of Internal Medicine, Division Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA., Lengerke-Diaz PA; Department of Internal Medicine, Division Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA., Moreno-Cortes E; Department of Internal Medicine, Division Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA., Melody M; Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA., Rahman ZA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, FL, USA., Rosenthal AC; Department of Internal Medicine, Division Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA., Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, FL, USA., Castro JE; Department of Internal Medicine, Division Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA.

Source: Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2023 Jan 17; Vol. 16 (2), pp. 133-143. Date of Electronic Publication: 2023 Jan 17.

Publication Type: Journal Article

Journal Info: Publisher: Scientific Publications Country of Publication: Saudi Arabia NLM ID: 101468532 Publication Model: Electronic Cited Medium: Internet ISSN: 2589-0646 (Electronic) Linking ISSN: 25890646 NLM ISO Abbreviation: Hematol Oncol Stem Cell Ther Subsets: MEDLINE

18
Academic Journal

Authors: Thomas S; Leibniz Institute for Immunotherapy, Div. Genetic Immunotherapy, Regensburg, Germany.; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Abken H; Leibniz Institute for Immunotherapy, Div. Genetic Immunotherapy, Regensburg, Germany.; Chair for Genetic Immunotherapy, University Regensburg, Regensburg, Germany.

Source: Frontiers in immunology [Front Immunol] 2023 Jan 09; Vol. 13, pp. 1090959. Date of Electronic Publication: 2023 Jan 09 (Print Publication: 2022).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

19
Academic Journal

Authors: Qin C; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Tian DS; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Zhou LQ; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Shang K; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Huang L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China., Dong MH; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., You YF; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Xiao J; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Xiong Y; Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China., Wang W; Nanjing IASO Biotherapeutics Ltd, Nanjing, China., Pang H; Nanjing IASO Biotherapeutics Ltd, Nanjing, China., Guo JJ; Nanjing IASO Biotherapeutics Ltd, Nanjing, China., Cai SB; Nanjing IASO Biotherapeutics Ltd, Nanjing, China., Wang D; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China., Li CR; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China., Zhang M; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Bu BT; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China., Wang W; Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030, Wuhan, China. wwang@tjh.tjmu.edu.cn.; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, 430030, Wuhan, China. wwang@tjh.tjmu.edu.cn.

Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2023 Jan 04; Vol. 8 (1), pp. 5. Date of Electronic Publication: 2023 Jan 04.

Publication Type: Clinical Trial, Phase I; Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

20
Academic Journal

Authors: Conde E; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Casares N; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Mancheño U; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Elizalde E; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Vercher E; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Capozzi R; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Santamaria E; Hepatology Program, CIMA, University of Navarra, Pamplona, 31008 Navarra, Spain; CIBERehd, Instituto de Salud Carlos III, 28029 Madrid, Spain., Rodriguez-Madoz JR; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Hemat-Oncology Program, CIMA Universidad de Navarra, Pamplona, 31008 Navarra, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain., Prosper F; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Hemat-Oncology Program, CIMA Universidad de Navarra, Pamplona, 31008 Navarra, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain; Hematology and Cell Therapy Department, Clínica Universidad de Navarra, Pamplona, 31008 Navarra, Spain., Lasarte JJ; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain., Lozano T; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain. Electronic address: tlmoreda@unav.es., Hervas-Stubbs S; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; Instituto de Investigación Sanitaria de Navarra (IdiSNA), Avenida Pio XII 55, Pamplona, 31008 Navarra, Spain; CIBERehd, Instituto de Salud Carlos III, 28029 Madrid, Spain. Electronic address: mshervas@unav.es.

Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2023 Jan 04; Vol. 31 (1), pp. 48-65. Date of Electronic Publication: 2022 Aug 31.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE